Anebulo Pharmaceuticals Inc (ANEB)
1.95
+0.04
(+2.09%)
USD |
NASDAQ |
Oct 04, 16:00
Anebulo Pharmaceuticals Shareholders Equity (Annual): 3.812M for June 30, 2024
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| June 30, 2024 | 3.812M |
| June 30, 2023 | 10.60M |
| June 30, 2022 | 15.07M |
| Date | Value |
|---|---|
| June 30, 2021 | 21.41M |
| June 30, 2020 | -0.1711M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-0.1711M
Minimum
2020
21.41M
Maximum
2021
10.14M
Average
10.60M
Median
2023
Shareholders Equity (Annual) Benchmarks
| Revance Therapeutics Inc | -151.60M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 39.70M |